US4308029A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and capillary tube for treating blood sample
Assignee: Radiometer AS
•
Filing: 1980-05-05
•
Granted: 1981-12-29
•
Expires: 2000-05-05
Abstract
Abstract Deoxygenation of a blood sample prior to determination of carbon monoxide hemoglobin is performed in a capillary tube containing a dry reducing agent. Ready for use capillary tubes having long storage life contain dry reducing agent and are sealed at both ends. Preferred capillary tubes contain mixture of reducing agent, pH buffer and anticoagulating agent present as a dry material on the interior tube wall.
Inventors
- 👤 Ole Siggaard-Andersen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 19:28
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; Y; Y10; Y10T; Y10T436/00; Y10T436/20; Y10T436/204998; Y10T436/205831; Y10T436/25; Y10T436/25125
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
55 words
A method of deoxygenating a blood sample, comprising breaking the seal of an air-tightly sealed capillary tube containing a dry reducing agent for the oxygen content of the blood, introducing the blood sample into the unsealed capillary tube containing said dry reducing agent, and allowing the action of the reducing agent on the blood sample.
Claim 2
Independent Claim
55 words
A method of deoxygenating a blood sample, comprising breaking the seal of an air-tightly sealed capillary tube containing a dry reducing agent for the oxygen content of the blood, introducing the blood sample into the unsealed capillary tube containing said dry reducing agent, and allowing the action of the reducing agent on the blood sample.
Claim 3
Dependent Claim
65 words
A method as claimed in claim 1 wherein the capillary tube is filled up completely with the blood sample and is thereafter sealed at both ends, and the blood sample and the reducing agent are mixed with each other in the capillary tube by means of a ferromagnetic body placed in the capillary tube and moved by means of a magnet outside the capillary tube.
Claim 4
Dependent Claim
13 words
A method according to claim 1, wherein said blood sample is whole blood.
Claim 5
Dependent Claim
27 words
A method according to claim 1, wherein the carbon monoxide hemoglobin content of said blood sample is determined after said reducing agent acts upon said blood sample.
Claim 6
Dependent Claim
51 words
A capillary tube for use in a method for deoxygenating blood, comprising an air-tightly sealed capillary tube containing a dry reducing agent for reducing the oxygen content of blood in a sufficient amount for reducing the oxygen content of the volume of blood which can be contained in the capillary tube.
Claim 7
Dependent Claim
51 words
A capillary tube for use in a method for deoxygenating blood, comprising an air-tightly sealed capillary tube containing a dry reducing agent for reducing the oxygen content of blood in a sufficient amount for reducing the oxygen content of the volume of blood which can be contained in the capillary tube.
Claim 8
Dependent Claim
26 words
A capillary tube as claimed in claim 5 wherein the reducing agent is present as a solid material on the interior wall of the capillary tube.
Claim 9
Dependent Claim
15 words
A capillary tube as claimed in claim 5 wherein the reducing agent is sodium dithionite.
Claim 10
Dependent Claim
14 words
A capillary tube as claimed in claim 5 which additionally contains a pH buffer.
Claim 11
Dependent Claim
36 words
A capillary tube as claimed in claim 5 which contains a mixture of a reducing agent, a pH buffer and an anticoagulating agent present as a solid composition on the interior wall of the capillary tube.
Claim 12
Dependent Claim
13 words
A capillary tube according to claim 5, wherein said blood is whole blood.
Claim 13
Dependent Claim
14 words
A capillary tube as claimed in claim 5 which additionally contains an anticoagulating agent.
Claim 14
Dependent Claim
28 words
A capillary tube as claimed in claim 11 wherein the anticoagulating agent is heparin, trisodium citrate, disodium salt of ethylenediamine-tetraacetic acid, sodium fluoride or an alkali metal oxalate.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-12-28 | 1985-06-29 | 1985-12-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-12-28 | 1989-06-29 | 1989-12-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-12-28 | 1993-06-29 | 1993-12-29 | $7700.00 | Window Closed / Lapsed |